Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program.
Saved in:
| Title: | Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program. |
|---|---|
| Authors: | Weinstock A; University at Buffalo/Oishei Children's Hospital, Buffalo, New York, USA., Bebin EM; University of Alabama Birmingham, Birmingham, Alabama, USA., Checketts D; Jazz Pharmaceuticals, Inc, Cambridge, UK., Clark GD; Texas Children's Hospital/Baylor College of Medicine, Houston, Texas, USA., Szaflarski JP; University of Alabama Birmingham, Birmingham, Alabama, USA., Seltzer LE; University of Rochester Medical Center, Rochester, New York, USA., Thiele EA; Massachusetts General Hospital, Boston, Massachusetts, USA., Sahebkar F; Jazz Pharmaceuticals, Inc, Carlsbad, California, USA. |
| Source: | Epilepsia open [Epilepsia Open] 2024 Oct; Vol. 9 (5), pp. 1816-1825. Date of Electronic Publication: 2024 Aug 01. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101692036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9239 (Electronic) Linking ISSN: 24709239 NLM ISO Abbreviation: Epilepsia Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2470-9239 |
|---|---|
| DOI: | 10.1002/epi4.13013 |
